leisure time -WSS

leisure time

author：knowledge 2025-10-02 00:18:05 - browse：189

A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home — A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways.

The ‘razor blade’ business model

Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes — almost 70% of its $184 million revenue in 2023 came from these supplies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Multiple sclerosis has subtypes with different best treatments: study

Wikipedia

WSS

Drug companies' payments and gifts affect physicians' prescribing

Bird flu in dairy cattle: New measures to control spread to humans

Overprescribed: High cost isn't America's only drug problem

Trial using CRISPR to edit HIV out of cells disappoints

Mass General Brigham physicians react to latest merger step

New documents shed light on MD Anderson Cancer Institute feud

knowledge

leisure time

The ‘razor blade’ business model

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Continuity nursing helped my family in our darkest PICU moments

Researchers test human milk's ability to repair gut microbiome

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Florida Supreme Court upholds state's abortion ban

As demand for Covid shots wanes, Moderna seeks its next success

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Affirmative action in medical school literally saved lives

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Bright Health sells Medicare Advantage business to Molina

Community Health Systems hospitals under DOJ investigation

hotspot

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Scientists uncover potential path to treating deadly childhood tumor

U.K. decision on ALS drug has neurologists, advocates up in arms

Covid silver lining: Unprecedented look at human immune system

The Harvard botanist who searched for psychedelics in the Amazon

New documents shed light on MD Anderson Cancer Institute feud

focus

focus

Wikipedia

focus